Back to 
Susquehanna International Group, LLP
Susquehanna International Group, LLP
XERS
19 quarters
Position history for Susquehanna International Group, LLP's holdings in Xeris Biopharma Holdings, Inc.
Yes. Susquehanna International Group holds 139,918 shares of XERS, worth $1.1M, as of its Q2 2026 13F filing. It reduced the position by 146,153 shares (-51.1%) from Q1 2026. Susquehanna International Group has held XERS in every 13F on record since Q4 2021, 19 quarterly filings.
Current Value
$1.1M
Current Shares
139,918
Total Value Change
-$1.3M
Total Shares Change
-694,618
Quarter-by-Quarter History
Other major holders of XERS: BlackRock, Inc., Vanguard Group Inc.